05-01-2020, 03:38 PM
The article states their is one ongoing clinical trial already and another one starting up. If anything better than a hint of efficacy is seen in these trials there will at a minimum be further trials. Safety is less of a consideration with drugs that are already approved for different indications, so that will help a lot. Still very early days here.